Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?

Fred R. Hirsch

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	363-364
Number of pages	2
Journal	Translational Lung Cancer Research
Volume	3
Issue number	6
DOIs	https://doi.org/10.3978/j.issn.2218-6751.2014.11.07
State	Published - 2014
Externally published	Yes

Access to Document

@article{bbfe5dfa5c03437ebaccd912c32624b2,

title = "Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?",

author = "Hirsch, {Fred R.}",

year = "2014",

doi = "10.3978/j.issn.2218-6751.2014.11.07",

language = "English",

volume = "3",

pages = "363--364",

journal = "Translational Lung Cancer Research",

issn = "2226-4477",